New research has found intranasally administered esketamine's effects are short-lived. tDCS shows promise for depression, ondansetron has limited OCD impact, and Cobenfy enhances cognition in schizophrenia.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Researchers will present findings at the American Academy of Neurology’s 77th Annual Meeting on how OTC pain relievers may be linked to faster concussion recovery.